ASX:BOTPharmaceuticals
Will Botanix Pharmaceuticals’ (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?
Botanix Pharmaceuticals recently held a special call to update investors on its quarterly activity report and Sofdra® topical gel launch, and is set to present at the 2025 Canaccord Genuity Drug & Device Conference with CEO Howie McKibbon as speaker.
These events highlight the company's efforts to communicate operational progress and product momentum to the market at key industry forums.
We’ll explore how management’s proactive communication on the Sofdra launch is shaping Botanix...